AstraZeneca PLC

AZNNYSE • USD
ThemeHealthcare - Oncology›Immunotherapy & Immuno-Oncology
185.68 USD
↗ 2.66 (1.45%)AT CLOSE (11:59 AM EDT)
185.00
↘ 0.68 (0.37%)
POST MARKET (AS OF 07:09 PM EDT)
Post Market
AS OF 07:09 PM EDT
185.00
↘ 0.68 (0.37%)
🔴Market: CLOSED

Shares of AstraZeneca PLC (AZN) are trading at $185.64. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9 and a bullish Golden Cross on the moving averages. On the valuation front, AZN trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Jun 25, 2026.

Open?$184.82
High?$186.58
Low?$184.55
Prev. Close?$183.02
Volume?1.8M
Avg. Volume?1.9M
VWAP?$185.48
Rel. Volume?0.98x
Bid / Ask
Bid?$177.00 × 100
Ask?$188.47 × 100
Spread?$11.47
Midpoint?$182.74
Valuation & Ratios
Market Cap?288.0B
Shares Out?N/A
P/E Ratio?198.46
P/B Ratio?19.39
EPS?$0.94
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Themes
Healthcare - Oncology›Immunotherapy & Immuno-OncologyBiotech - Drug Development›Metabolic & CardiometabolicHealthcare - Genomics & Precision Medicine›Precision Medicine Platforms
Employees
96.1K
Market Cap
283.8B
Industry
N/A
Website
www.astrazeneca.com
Listed
2009-10-23
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
97
Momentum?
50
Short Sent.?
63
Piotroski F-Score?0/9Weak
Altman Z-Score?4.83Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestLow
Short Interest?1.3M
Days to Cover?1.0
Avg Daily Volume2.1M
Settlement Date2026-06-15
Financial Health
Current Ratio?0.87Weak
Quick Ratio?0.72Weak
Cash Ratio?0.33Low
Debt/Equity?1.77High
ValuationRICHLY VALUEDvs 10 peers + S&P 500
Score
33/100
P/E?
Peers
11
S&P
3
198.5PRICEY▾
P/B?
Peers
33
S&P
8
19.39HIGH▾
P/S?
Peers
9
S&P
3
15.89HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
10
S&P
3
86.3HIGH▾
EV/Sales?
Peers
9
S&P
3
17.07HIGH▾
Returns & Efficiency
ROE?
Peers
33
S&P
33
9.8%FAIR▾
ROA?
Peers
11
S&P
22
2.3%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$309.2B
Fundamentals ratios updated end of day
MarketsMoversWatchlist